These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 28509408
1. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done? Brown A, Guess N, Dornhorst A, Taheri S, Frost G. Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408 [Abstract] [Full Text] [Related]
2. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes. Lau DC, Teoh H. Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858 [Abstract] [Full Text] [Related]
3. Insulin treatment and the problem of weight gain in type 2 diabetes. Carver C. Diabetes Educ; 2006 Dec; 32(6):910-7. PubMed ID: 17102158 [Abstract] [Full Text] [Related]
4. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Russell-Jones D, Khan R. Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864 [Abstract] [Full Text] [Related]
5. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial. Out M, Miedema I, Jager-Wittenaar H, van der Schans C, Krijnen W, Lehert P, Stehouwer C, Kooy A. Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986 [Abstract] [Full Text] [Related]
6. Insulin therapy and type 2 diabetes: management of weight gain. McFarlane SI. J Clin Hypertens (Greenwich); 2009 Oct; 11(10):601-7. PubMed ID: 19817944 [Abstract] [Full Text] [Related]
7. Severe hypoglycemia in the Look AHEAD Trial. Look AHEAD Research Group (Appendix A), Greenway FL. J Diabetes Complications; 2016 Jul; 30(5):935-43. PubMed ID: 27114389 [Abstract] [Full Text] [Related]
8. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes. Lau DC, Teoh H. Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857 [Abstract] [Full Text] [Related]
9. Use of insulin and weight gain: optimizing diabetes nutrition therapy. Daly A. J Am Diet Assoc; 2007 Aug; 107(8):1386-93. PubMed ID: 17659906 [Abstract] [Full Text] [Related]
10. Does insulin detemir have a role in reducing risk of insulin-associated weight gain? Hermansen K, Davies M. Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147 [Abstract] [Full Text] [Related]
11. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach. Nadeau DA. Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512 [Abstract] [Full Text] [Related]
12. The management of the obese diabetic patient. Albu J, Raja-Khan N. Prim Care; 2003 Jun; 30(2):465-91. PubMed ID: 14567159 [Abstract] [Full Text] [Related]
13. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus. Fassberg J, Toffler WL, Fields SA, Loriaux LD. J Fam Pract; 1993 Jul; 37(1):76-81. PubMed ID: 8345343 [Abstract] [Full Text] [Related]
14. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? van Raalte DH, Verchere CB. Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962 [Abstract] [Full Text] [Related]
15. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus). Cheah JS. Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503 [Abstract] [Full Text] [Related]
16. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain? Ryan M, Livingstone MB, Ducluzeau PH, Sallé A, Genaitay M, Ritz P. Diabetes Care; 2008 Mar; 31(3):448-50. PubMed ID: 18086874 [Abstract] [Full Text] [Related]
17. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Heller S. Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867 [Abstract] [Full Text] [Related]
19. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease. Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G. Diabete Metab; 1993 May; 19(1):30-5. PubMed ID: 8504882 [Abstract] [Full Text] [Related]
20. Diabetes and weight management. Lau DC. Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S24-30. PubMed ID: 20394888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]